These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10211316)

  • 1. Cell kinetics of mouse tumour subjected to photodynamic therapy--evaluation by proliferating cell nuclear antigen immunohistochemistry.
    Uehara M; Inokuchi T; Sano K; Sekine J; Ikeda H
    Oral Oncol; 1999 Jan; 35(1):93-7. PubMed ID: 10211316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy.
    Uehara M; Inokuchi T; Sano K; ZuoLin W
    Eur J Cancer; 2001 Nov; 37(16):2111-5. PubMed ID: 11597392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft.
    Togashi H; Uehara M; Ikeda H; Inokuchi T
    Oral Oncol; 2006 May; 42(5):526-32. PubMed ID: 16466960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of heat shock protein 47 in the fibrous tissue adjacent to mouse tumour subjected to photodynamic therapy.
    Uehara M; Inokuchi T; Tobita T; Ohba S; Asahina I
    Oral Oncol; 2007 Sep; 43(8):804-10. PubMed ID: 17174144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermic photodynamic therapy combined with topical administration of OK-432 in the mouse carcinoma.
    Uehara M; Inokuchi T
    Oral Oncol; 2003 Feb; 39(2):184-9. PubMed ID: 12509973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma.
    Uehara M; Sano K; Wang ZL; Sekine J; Ikeda H; Inokuchi T
    Cancer Immunol Immunother; 2000 Oct; 49(8):401-9. PubMed ID: 11043846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cell death in NR-S1 tumor by photodynamic therapy: possible involvement of Fas and Fas ligand system.
    Yokota T; Ikeda H; Inokuchi T; Sano K; Koji T
    Lasers Surg Med; 2000; 26(5):449-60. PubMed ID: 10861700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin.
    Uehara M; Inokuchi T; Ikeda H
    J Oral Maxillofac Surg; 2006 Mar; 64(3):390-6. PubMed ID: 16487799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour destruction and proliferation kinetics following periodic, low power light, haematoporphyrin oligomers mediated photodynamic therapy in the mouse tongue.
    Pe MB; Ikeda H; Inokuchi T
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):174-8. PubMed ID: 7920163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases.
    Wagner M; Suarez ER; Theodoro TR; Machado Filho CD; Gama MF; Tardivo JP; Paschoal FM; Pinhal MA
    Clin Exp Dermatol; 2012 Jul; 37(5):527-33. PubMed ID: 22299594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
    Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H
    J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia.
    Uehara M; Ikeda H; Nonaka M; Sumita Y; Nanashima A; Nonaka T; Asahina I
    Arch Oral Biol; 2011 Nov; 56(11):1366-72. PubMed ID: 21596370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy-generated vaccines: relevance of tumour cell death expression.
    Korbelik M; Stott B; Sun J
    Br J Cancer; 2007 Nov; 97(10):1381-7. PubMed ID: 17971767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric analysis of mouse tumor nuclei subjected to photodynamic therapy.
    Uehara M; Sekine J; Wang Z; Inokuchi T
    J Oral Maxillofac Surg; 2005 Feb; 63(2):244-6. PubMed ID: 15690295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy.
    Korbelik M; Zhang W; Separovic D
    Photochem Photobiol Sci; 2012 May; 11(5):779-84. PubMed ID: 22354109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating effect of beta-glucans on photodynamic therapy of implanted cancer cells in mice.
    Akramiene D; Aleksandraviciene C; Grazeliene G; Zalinkevicius R; Suziedelis K; Didziapetriene J; Simonsen U; Stankevicius E; Kevelaitis E
    Tohoku J Exp Med; 2010 Apr; 220(4):299-306. PubMed ID: 20410681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
    Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
    Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological change of oral malignant tumour and epithelial dysplasia subjected to photodynamic therapy.
    Uehara M; Ikeda H; Nonaka M; Asahina I
    J Oral Maxillofac Res; 2010; 1(3):e5. PubMed ID: 24421975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in perfusion of mouse tumours after photodynamic therapy.
    van Geel IP; Oppelaar H; Oussoren YG; Stewart FA
    Int J Cancer; 1994 Jan; 56(2):224-8. PubMed ID: 8314306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.